PDL BioPharma (PDLI) PT Lowered to $2.50 at Cowen

June 12, 2018 9:58 AM

Cowen lowered its price target on PDL BioPharma (NASDAQ: PDLI) to $2.50 (from $3.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found